Morning Briefing

"[P]eople everywhere have a stake in eradicating polio, as we have stamped out smallpox," a Bloomberg View editorial states, adding, "Immunizing the last unvaccinated children on the planet is an expensive and complex undertaking, and worth it in the long run." The editorial notes, "If polio transmission could be stopped by 2015, the net benefit from reduced treatment costs and productivity gains through 2035 would be $40 billion to $50 billion, according to a 2010 study."